Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects

被引:494
作者
Gastaldelli, Amalia
Cusi, Kenneth
Pettiti, Maura
Hardies, Jean
Miyazaki, Yoshinori
Berria, Rachele
Buigoli, Emma
Sironi, Anna Maria
Cersosimo, Eugenio
Ferrannini, Ele
Defronzo, Ralph A.
机构
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] Univ Texas, Hlth Sci Ctr, Dept Med, Div Diabet, San Antonio, TX USA
[3] Case Western Reserve Univ, Dept Obstet Gynecol, Cleveland, OH USA
[4] Univ Pisa, Dept Internal Med, Pisa, Italy
关键词
D O I
10.1053/j.gastro.2007.04.068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG). MethodS: In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-H-3-glucose) and GNG ((H2O)-H-2) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (1,17) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging. Results: LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 mu mol/min/kg(ffm); P =.02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 mu mol/min/kg(ffm); P= .02). Basal hepatic IR index (EGP X fasting plasma insulin) was increased in T2DM (NGT, 816 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P =.007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05). Conclusions: Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 40 条
[1]   Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Hardies, LJ ;
Pratipanawatr, T ;
DeFronzo, RA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (06) :783-789
[2]   Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes [J].
Bajaj, M ;
Suraamornkul, S ;
Pratipanawatr, T ;
Hardies, LJ ;
Pratipanawatr, W ;
Glass, L ;
Cersosimo, E ;
Miyazaki, Y ;
DeFronzo, RA .
DIABETES, 2003, 52 (06) :1364-1370
[3]   Surgical removal of visceral fat reverses hepatic insulin resistance [J].
Barzilai, N ;
She, L ;
Liu, BQ ;
Vuguin, P ;
Cohen, P ;
Wang, JL ;
Rossetti, L .
DIABETES, 1999, 48 (01) :94-98
[4]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[5]   METABOLIC ABNORMALITIES IN VISCERAL OBESITY [J].
BJORNTORP, P .
ANNALS OF MEDICINE, 1992, 24 (01) :3-5
[6]   TOTAL-BODY FAT-CONTENT AND FAT TOPOGRAPHY ARE ASSOCIATED DIFFERENTLY WITH INVIVO GLUCOSE-METABOLISM IN NONOBESE AND OBESE NONDIABETIC WOMEN [J].
BONORA, E ;
DELPRATO, S ;
BONADONNA, RC ;
GULLI, G ;
SOLINI, A ;
SHANK, ML ;
GHIATAS, AA ;
LANCASTER, JL ;
KILCOYNE, RF ;
ALYASSIN, AM ;
DEFRONZO, RA .
DIABETES, 1992, 41 (09) :1151-1159
[7]   Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms [J].
Bugianesi, E ;
Gastaldelli, A ;
Vanni, E ;
Gambino, R ;
Cassader, M ;
Baldi, S ;
Ponti, V ;
Pagano, G ;
Ferrannini, E ;
Rizzetto, M .
DIABETOLOGIA, 2005, 48 (04) :634-642
[8]   Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[9]   Intramuscular and liver triglycerides are increased in the elderly [J].
Cree, MG ;
Newcomer, BR ;
Katsanos, CS ;
Sheffield-Moore, M ;
Chinkes, D ;
Aarsland, A ;
Urban, R ;
Wolfe, RR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3864-3871
[10]   FASTING HYPERGLYCEMIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - CONTRIBUTIONS OF EXCESSIVE HEPATIC GLUCOSE-PRODUCTION AND IMPAIRED TISSUE GLUCOSE-UPTAKE [J].
DEFRONZO, RA ;
FERRANNINI, E ;
SIMONSON, DC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (04) :387-395